ACC Cardiology Hour – Hottest Trials From ESC 2018

Posted by Structural Heart Disease Australia | Research Update |

The editor of JACC Valentin Fuster hosts a roundtable discussion on the 9 major trials presented at the recent European Society of Cardiology Meeting 2018.

http://www.onlinejacc.org/cardiologyhour

CULPRIT SHOCK(3:54)
LRT – TAVR in Low-Risk Patients with Symptomatic AS(13:23)
MITRA-FR(21:30)
Validation of DAPT Score(29:40)
GLOBAL LEADERS(38:25)
ASCEND (aspirin)(46:47)
ASCEND (Omega-3)(55:50)
ARRIVE(57:00)
ATTR-ACT(1:01:34)

About The Author

Structural Heart Disease Australia

Structural Heart Disease Australia is an incorporated association focused on education in valvular and structural cardiac diseases. It was started by group of echocardiographers, anaesthetists, clinical and interventional cardiologists, and cardiothoracic surgeons to provide a useful learning resource for medical professionals.